Toggle navigation
Home
Search
Services
Blog
Contact
About
Novel Recombinant Serpin for the Treatment of Stroke
Sands, Howard
Sparta Pharmaceutical Corporation, Horsham, PA, United States
Search 7 grants from Howard Sands
Search grants from Sparta Pharmaceutical Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Determine the role of TLR1 signaling in chronic inflammation and colorectal cance
Novel Photoreceptor Proteins and Retinal Degenerations
Photo-assisted targeting of immunotherapy to the bladder
A Monoclonal Antibody Immunoprotectant for Ebola Virus
Cognitive Skills in Children
Recently added grants:
Molecular mechanism of CPG15 mediated activity-dependent synaptic plasticity
Retinoic acid gene regulatory networks in the mammalian kidney
Mechanisms controlling distal nephron maturation
Functional analysis of SBP2 and selenocysteine incorporation
Regulation of experience-dependent cortical circuit development by MEF2C and genes linked to neurodevelopmental disorders
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44NS036100-03
Application #
2771968
Study Section
Special Emphasis Panel (ZRG3-SSS-Z (11))
Program Officer
Jacobs, Tom P
Project Start
1995-08-15
Project End
1999-08-31
Budget Start
1998-09-01
Budget End
1999-08-31
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Institution
Name
Sparta Pharmaceutical Corporation
Department
Type
DUNS #
City
Horsham
State
PA
Country
United States
Zip Code
19044
Related projects
NIH 1998
R44 NS
Novel Recombinant Serpin for the Treatment of Stroke
Sands, Howard / Sparta Pharmaceutical Corporation
NIH 1997
R44 NS
Novel Recombinant Serpin for the Treatment of Stroke
Sands, Howard / Sparta Pharmaceutical Corporation
Comments
Be the first to comment on Howard Sands's grant